CMP vs EYE

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

CMP

COMPUMEDIC FPO [CMP]

54MEDIUM

EYE

NOVA EYE FPO [EYE]

58MEDIUM

Score Breakdown

CMP EYE
Technical
32
46
Catalyst
54
54
Sentiment
50
50
Fundamental
85
60
Momentum
47
65
Risk Gate
47
50

Key Metrics

CMP Metric EYE
$54.9MMarket Cap$38.5M
65KAvg Volume (20d)199K
N/AShort InterestN/A
$0.45052-Week High$0.205
$0.21552-Week Low$0.100
-14.6%Daily Change+3.8%
$0.235Reference Price$0.135
+1.0%ROE-26.1%
+0.3%Profit Margin-12.4%

Active Signals

CMP Signals

●Volume surging at 4.7x normal while price falls — heavy selling pressure
●Drifting lower — down 7.8% over the last 5 days
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.9x)
●Moderate revenue growth (+12%)
●Piotroski F-Score strong (7/9, low-confidence approx)

EYE Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (1.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

Ask Scout AI to compare CMP and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs PIQ →IIQ vs LGP →ARX vs AVE →ARX vs DOC →ARX vs SOM →
CMP Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).